For instance, HDAC inhibitors like suberoylanilide hydroxamic acid (SAHA) and CKD-504 have demonstrated neuroprotective effects in HD models, partly by increasing BDNF expression (Mielcarek et al. 2011; Li et al. 2023). This evidence concerns the gene BDNF and Huntington disease.